Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

A Novel Pathologic Variant in OTOF in an Iranian Family Segregating Hereditary Hearing Loss.

Authors:
Mohammad Amin Tabatabaiefar Mohammad Reza Pourreza Parisa Tahmasebi Nader Saki Morteza Hashemzadeh Chaleshtori Rasoul Salehi Javad Mohammadi-Asl

Otolaryngol Head Neck Surg 2018 06 27;158(6):1084-1092. Epub 2018 Feb 27.

6 Department of Medical Genetics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Objective Hearing loss (HL) is the most common sensory-neural defect and the most heterogeneous trait in humans, with the involvement of >100 genes, which make a molecular diagnosis problematic. Next-generation sequencing (NGS) is a new strategy that can overcome this problem. Study Design Descriptive experimental study. Setting Diagnostic laboratory. Subjects and Methods A comprehensive family history was obtained, and clinical evaluations and pedigree analysis were performed in a family with multiple individuals with HL. As the first tier, GJB2 was sequenced, and genetic linkage analysis of DFNB1A/B was performed to rule out the most common cause of the disease. Targeted NGS was used to unravel the molecular etiology of the disease in the HL-associated genes in the proband. Two homozygous variants remained in OTOF after proper filtration. Cosegregation and in silico analysis were done. Preimplantation genetic diagnosis (PGD) was accomplished via linkage analysis and direct sequencing of the pathogenic variant. Results Clinical evaluations suggested autosomal recessive nonsyndromic HL. Two homozygous variants, c.367G>A (p.Gly123Ser) and c.1392+1G>A, were identified in cis status. c.1392+1G>A met the criteria for being pathogenic according to the variant interpretation guideline of the American College of Medical Genetics and Genomics. PGD was successfully performed to prevent the recurrence of the disease in the related family. Conclusion A novel OTOF mutation causing HL was identified. Here, we report the effectiveness of the combined application of targeted NGS and PGD in diagnosis and prevention of hereditary HL.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0194599818759007DOI Listing
June 2018

Publication Analysis

Top Keywords

targeted ngs
8
linkage analysis
8
hearing loss
8
clinical evaluations
8
homozygous variants
8
pathogenic variant
8
filtration cosegregation
4
proper filtration
4
remained otof
4
proband homozygous
4
variants remained
4
cosegregation silico
4
otof proper
4
preimplantation genetic
4
accomplished linkage
4
analysis direct
4
direct sequencing
4
sequencing pathogenic
4
pgd accomplished
4
diagnosis pgd
4

Keyword Occurance

Similar Publications

Commercially available blocking oligonucleotides effectively suppress unwanted hemolysis related miRNAs in a large whole blood RNA cohort.

Authors:
Jenna LaBelle Mark Bowser Alison Brown Leanna Farnam Alvin Kho Jiang Li Michael McGeachie Robert Chase Shannon Piehl Kevin Allen Brian D Hobbs Scott T Weiss Craig Hersh Kelan Tantisira Sami S Amr

J Mol Diagn 2021 Apr 16. Epub 2021 Apr 16.

Partners Healthcare Personalized Medicine, Partners Healthcare; 65 Landsdowne St, Cambridge, MA; Dept of Pathology, Brigham and Women's Hospital, and Harvard Medical School; 75 Francis St, Boston, MA. Electronic address:

When sequencing small RNA libraries derived from whole blood, three of the most abundant miRs detected are often miR-486-5p, miR-451a, and miR-92a-3p. These highly expressed erythropoietic miRs are released into the sample due to red blood cell hemolysis. Next generation sequencing of these unwanted miRs leads to a huge waste in sequencing cost and diminished detection of lowly expressed miRNAs, including many potential miRNA biomarkers. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Prognostic factor identification by screening changes in differentially expressed genes in oral squamous cell carcinoma.

Authors:
Boris Schminke Orr Shomroni Gabriela Salinas Felix Bremmer Philipp Kauffmann Henning Schliephake Felix Oyelami Michal A Rahat Phillipp Brockmeyer

Oral Dis 2021 Apr 19. Epub 2021 Apr 19.

Department of Oral and Maxillofacial Surgery, University Medical Center, Goettingen, Germany.

Objective: This study was designed to identify changes in the expression of proteins occurring during the progression of oral squamous cell carcinoma (OSCC) and to validate their impact on patient prognosis.

Materials And Methods: The human OSCC cell line UPCI-SCC-040 was treated in vitro with TGF-β1, and transcriptome analysis of differentially expressed genes (DEGs) revealed putative candidates relative to untreated cells. The respective protein expression levels of the most important genes were immunohistochemically validated on a tissue microarray (TMA) containing tissue samples from 39 patients with OSCC and were correlated with disease-free survival (DFS) as the primary clinical endpoint. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Association of Body Mass Index With Somatic Mutations in Breast Cancer.

Authors:
Bo Chen Liping Guo Kai Li Weikai Xiao Yingzi Li Cheukfai Li Hsiaopei Mok Li Cao Jiali Lin Guangnan Wei Guochun Zhang Ning Liao

Front Oncol 2021 1;11:613933. Epub 2021 Apr 1.

Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.

Background: The relationship between body mass index (BMI) and the prognosis or treatment response in patients with breast cancer has been demonstrated in previous studies, but the somatic mutation profiles in breast cancer patients with different BMIs have not been explored.

Methods: In the present study, the somatic mutation profiles in 421 female breast cancer patients who were stratified into three subgroups based on BMI (normal weight, overweight/obese, and underweight) were investigated. Capture-based targeted sequencing was performed using a panel comprising 520 cancer-related genes. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients.

Authors:
Duna H Barakeh Rasha Aljelaify Yara Bashawri Amal Almutairi Fatimah Alqubaishi Mohammed Alnamnakani Latifa Almubarak Abdulrahman Al Naeem Fatema Almushawah May Alrashed Malak Abedalthagafi

Oncotarget 2021 Mar 30;12(7):686-697. Epub 2021 Mar 30.

Genomics Research Department, Saudi Human Genome Project, King Fahad Medical City and King Abdulaziz City for Science and Technology, Riyadh, Kingdom of Saudi Arabia.

Breast cancer (BCa) ranks first in incidence rate among cancers in Arab females. The association between genetic polymorphisms in tumor suppressor genes and the risk of BCa has been studied in many ethnic populations with conflicting conclusions while Arab females and Saudi Arabian studies are still lacking. We screened a cohort of Saudi BCa patients by NGS using a bespoke gene panel to clarify the genetic landscape of this population, correlating and assessing genetic findings with clinical outcomes. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

A novel NCOR2-NTRK1 fusion detected in a patient of lung adenocarcinoma and response to larotrectinib: a case report.

Authors:
Lei Zhang Huanhuan Liu Ye Tian Huina Wang Xueying Yang

BMC Pulm Med 2021 Apr 17;21(1):125. Epub 2021 Apr 17.

Department of Thoracic Surgery, The Fourth Affiliated Hospital of China Medical University, 4 Chongshan East Road, Shenyang, 110032, Liaoning, People's Republic of China.

Background: The identification of NTRK fusions in tumours has become critically important due to the actionable events predictive of response to TRK inhibitor. It is not clear whether the NTRK breakpoint location is different for response to targeted therapy and NTRK fusions affects the efficacy of immunotherapy.

Case Presentation: Here we reported a 60-year-old female diagnosed with advanced lung adenocarcinoma. Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap